The Inhibitory Effect of HKa on Prostate Cancer Line DU145 Is Mediated by Blocking Metastasis

CSEF · 2008 Biochemistry/ Molecular Biology

Overview

Objectives/Goals Prostate Cancer is defined by the uncontrollable proliferation of prostate cells. When growth factors bind to their receptors, a transactivation signal is sent to EGFR and uPAR, resulting in clustering of EGFR and uPAR. This increases Cyclin D1 expression and facilitates migration of prostate cancer cells. High-molecular weight kininogen [HK] is a plasma protein responsible blood-clotting. Cleavage of HK results in the release of bradykinin and cleaved high molecular weight kininogen [HKa]. HKa induces apoptosis of proliferating epithelial cells and inhibits angiogenesis in vivo. The purpose of this experiment was to prevent the metastasis of prostate cancer cells through implementation of HKa. HKa would bind to uPAR and prevent the transactivation signaling from growth factors to EGFR. This competitive inhibition would inhibit metastasis of prostate cancer cells. Methods/Materials Sub-cultured Prostate Caner DU145 cells into six 35mm2 dishes coated with 1mL Collagen [10¥ìg/mL] until monolayer is formed. Measured metastasis/migration of Prostate Cancer DU145 cells in vitro through a Migration Assay. 3 dishes were Control. 3 dishes were HKa Treated. Added 6.09¥ìL HKa [100nM] to HKa Treated dishes. Added 2mL Pure Media [DMEM + L-Glut] with Zn2+ [15¥ìM] and 2¥ìL bFGF [20ng/mL] to each dish. Incubated each dish at 37¢ªC for 24 hours. After incubation, fixed tumor cells with 2mL Formalin Solution [1.2mL DPBS Buffer + 0.8mL 10% Formaldehyde] and incubated at 4¢ªC. Pictures of each migration line were taken at 0 and 24 hours to show contrast/growth of cells in the Control and HKa Treated dishes. Results EGFR and uPAR co-localized on the surface of Prostate Cancer DU145 cells in response to bFGF [20ng/ml]. Immunofluorescence microscopy showed that HKa disrupted co-localization of EGFR and uPAR, indicating that HKa prevented transactivation signaling from growth factors to EGFR. HKa inhibited migration of DU145 cells at 24 hours by the Migration Assay. A monoclonal antibody against uPAR also blocked migration of DU145 cells at 24 hours by the Migration Assay. It suggested that HKa inhibited migration of tumor cells by targeting uPAR. Conclusions/Discussion HKa disrupted the interaction of EGFR and uPAR and inhibited migration of Prostate Cancer DU145 cells across migration line. It indicates that HKa might prevent metastasis of human Prostate Cancer.

Summary statement

My project investigates the use of cleaved high molecular-weight kininogen, a plasma protein, in inhibiting the metastasis of Prostate Cancer Cell Line DU145 in vitro.

Help received

Participant in Physician Scientist Training Program; gained mentorship/workspace from faculty at Sol Sherry Thrombosis Research Center at Temple University School of Medicine in Philadelphia, PA.

Competition history

  • CSEF 2008 Biochemistry/ Molecular Biology · Entry S0419

Resources

Related projects

Closest projects by meaning, across every fair and year in the corpus.

Browse more like this

Source: California Science & Engineering Fair public projects

Save projects to your library

Sign in with Google to keep track of projects you find interesting, organized into folders. An account also raises your daily allowance for “Has this been done?”, and lets you create a key for the MCP server with a much higher limit than anonymous use. Browsing stays public.

Continue with Google